University of California, San Francisco Logo

University of California, San Francisco | About UCSF | Search UCSF | UCSF Medical Center

Home > Grand Rounds > Cases > Slides
Cases from the Clinic 2010
Slide Presentation
November 24, 2011
Dan Wlodarczyk MD

Click on slide thumbnails to view full-size image.

Slide 1.
Cases from the Clinic 2010
Slide 1.
My Thanks
Slide 2.
Catalogue of Maladies
Slide 3.
Breast Enlargement
Slide 4.
Next Steps
Slide 5.
D, let's get more info
Slide 6.
Breast Enlargement DDx
Slide 7.
Examination for Gynecomastia
Slide 8.
Conditions Associated with Gynecomastia
Slide 9.
Drugs Associated with Gynecomastia
Slide 10.
Med List
Slide 11.
Meds/Conditions that our Patient Has That Can Cause Gynecomastia or Lipomastia
Slide 12.
Efavirenz Associated Gynecomastia
Slide 13.
Our Patient with Breast Enlargement
Slide 14.
Tale of 2 Utoxs
Slide 15.
Prevalence of Pain in HIV/AIDS
Slide 16.
Utox #1
Slide 17.
His Utox is positive for methamphetamine and amphetamines, You conclude that:
Slide 18.
Utox and Dextroamphetamine (Dexedrine) Answer B
Slide 19.
What if he was taking?
Slide 20.
Summary
Slide 21.
Frida Kahlo lived much of her life in pain and underwent a number of spinal surgeries
Slide 22.
A pt of yours with chronic pain
Slide 23.
His Utox Report
Slide 24.
Based on his Utox that shows positive for morphine, opiates and codeine you conclude that:
Slide 25.
Interpretation of Urine Drug Testing, San Francisco General Hospital Toxicology Laboratory Opiate Metabolism
Slide 26.
A Rash Decision
Slide 27.
Plan to Start New Meds
Slide 28.
Summary of Resistance Mutations Observed
Slide 29.
A Rash Decision
Slide 30.
Advantages of Cell Phone Technology
Slide 31.
Thigh
Slide 32.
Foot
Slide 33.
What About His Rash?
Slide 34.
Answer B is most likely -- DUET Trial Adverse Events
Slide 36.
Rash in DUET
Slide 37.
9/24/2010 Co-receptor Tropism Assay
Slide 38.
Next Steps
Slide 39.
Sulfonamide Allergy and Cross-Reactivity
Slide 40.
Sulfonamide meds are classified into 3 general groups based on their structure
Slide 41.
Sulfonamide Allergy and Cross-Reactivity-2
Slide 42.
It Takes a Village
Slide 43.
Urgent Care Visit
Slide 44.
Next Steps
Slide 45.
MRSA
Slide 46.
German Village study*
Slide 47.
Risk Factors for Abscesses
Slide 48.
Successful Eradication of SA Abscesses in a German Village with Stringent Decolonization
Slide 49.
What Was Done
Slide 50.
Rifabutin Drug Interactions
Slide 51.
Table 3. Recommendations for Coadministering Antiretroviral Drugs with RIFABUTIN - 2007
Slide 51.
Interaction Report from www.hiv-druginteractions.org
Slide 51.
Recommended Rifabutin Dose May Be Inadequate for TB
Slide 54.
Clinical Infectious Diseases 2009;48:1471-1474
Slide 55.
3 People Who Can't Take Their Meds
Slide 56.
Can't or Won't Take Their Meds
Slide 57.
CD4 and VL
Slide 58.
Not Taking
Slide 59.
HIV and CNS
Slide 60.
Prevalence of Neurocognitive Impairment in Current Treatment Era
Slide 61.
Low CD4+ Count Nadir Associated With HIV-Associated Neurocognitive Disorders
Slide 62.
More on HIV and Aging
Slide 63.
Second Adherence Case
Slide 64.
2nd
Slide 65.
3rd Person Not Taking Her Meds
Slide 66.
Like Poison
Slide 67.
Posttest and evaluation

We request that all users complete the brief posttest and evaluation to provide feedback to course planners and presenters. Those requesting CME credit are required to complete all components to receive credit. Begin with the posttest.

About | Site Map | Feedback | Subscribe | Donate | Disclaimer

UCSF - Center for HIV Information HIV InSite is a project of the UCSF Center for HIV Information. Copyright 2013, Regents of the University of California.